StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Outside the United States by Quarter

Outside the United States (Ex-U.S. total net product revenues, $M) ($M)

QuarterlyAnnual

Vertex Pharmaceuticals Outside the United States: $1,278M in Q2 2026, up 14.4% from a year earlier. That is the highest of the 38 quarters on record here.

Latest, Q2 2026
1,278
Period ended Jun 30, 2026
Change on a year earlier
+14.4%
1,117 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
33
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Segment & Geographic Information Note.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOutside the United States (Ex-U.S. total net product revenues, $M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,278+14.4%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 20261,211+9.4%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 20251,129+5.1%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20251,100+3.9%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 20251,117+8.3%Form 10-Q (filed 2026-08-04) ↗
Q1 2025Mar 31, 20251,107-5.5%Form 10-Q (filed 2026-05-05) ↗
Q4 2024Dec 31, 20241,075+14.0%Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 20241,058+13.9%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 20241,031+4.7%Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 20241,171+20.6%Form 10-Q (filed 2025-05-06) ↗
Q4 2023Dec 31, 2023943+12.0%Form 10-K (filed 2026-02-13) ↗
Q3 2023Sep 30, 2023929+5.8%Form 10-Q (filed 2024-11-05) ↗
Q2 2023Jun 30, 2023985+26.2%Form 10-Q (filed 2024-08-02) ↗
Q1 2023Mar 31, 2023971+33.1%Form 10-Q (filed 2024-05-07) ↗
Q4 2022Dec 31, 2022842+24.1%Form 10-K (filed 2025-02-13) ↗
Q3 2022Sep 30, 2022879+46.2%Form 10-Q (filed 2023-11-07) ↗

Breakdown

What makes up outside the United States

Cite this data

StockData. (2026). Vertex Pharmaceuticals Outside the United States ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rev-geo-non-us

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.